Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cis
- This topic has 0 replies, 1 voice, and was last updated 5 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program.
https://www.ncbi.nlm.nih.gov/pubmed/30634942
https://clinicaltrials.gov/ct2/show/NCT01679405
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.